These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15780350)

  • 41. Another incentive to lose weight.
    Tan E; Chiang D
    Aust Fam Physician; 2006 May; 35(5):278. PubMed ID: 16708447
    [No Abstract]   [Full Text] [Related]  

  • 42. Changing demography of prostate cancer in Asia.
    Sim HG; Cheng CW
    Eur J Cancer; 2005 Apr; 41(6):834-45. PubMed ID: 15808953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I.
    Kawada M; Inoue H; Arakawa M; Ikeda D
    Anticancer Res; 2008; 28(2A):721-30. PubMed ID: 18507013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mitogenic and anti-apoptotic actions of adipocyte-derived hormone leptin in prostate cancer cells.
    Hoda MR; Popken G
    BJU Int; 2008 Aug; 102(3):383-8. PubMed ID: 18341625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mechanism of osteoblastic bone metastasis of prostate cancer].
    Yonou H; Ogawa Y; Ochiai A
    Clin Calcium; 2006 Apr; 16(4):557- 64. PubMed ID: 16582505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implications of insulin-like growth factor-I for prostate cancer therapies.
    Kojima S; Inahara M; Suzuki H; Ichikawa T; Furuya Y
    Int J Urol; 2009 Feb; 16(2):161-7. PubMed ID: 19183230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Haplotype-based analysis of common variation in the growth hormone receptor gene and prostate cancer risk.
    McKay JD; Kaaks R; Johansson M; Biessy C; Wiklund F; Bälter K; Adami HO; Boillot C; Gioia-Patricola L; Canzian F; Stattin P; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):169-73. PubMed ID: 17220348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Healthy life style seems to reduce the risk of cancer. New support for the hypothesis that overweight and high blood glucose increase the cancer risk].
    Stocks T; Lindahl B; Stattin P
    Lakartidningen; 2007 Dec; 104(51-52):3867-70. PubMed ID: 18232528
    [No Abstract]   [Full Text] [Related]  

  • 50. Obesity, metformin and prostate cancer risk.
    Rees J
    Practitioner; 2014 Dec; 258(1777):5. PubMed ID: 25603587
    [No Abstract]   [Full Text] [Related]  

  • 51. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
    Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
    J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin-like growth factor-I produced by seminal vesicles: relationship to intraepithelial basal cell hyperplasia in the prostate.
    Garcia FU; Urbanska K; Koltowski L; Reiss K; Sell C
    Clin Cancer Res; 2007 Jun; 13(11):3140-6. PubMed ID: 17545516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men.
    Gong Z; Agalliu I; Lin DW; Stanford JL; Kristal AR
    Cancer; 2007 Mar; 109(6):1192-202. PubMed ID: 17311344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anthropometrics and prostate cancer risk.
    Littman AJ; White E; Kristal AR
    Am J Epidemiol; 2007 Jun; 165(11):1271-9. PubMed ID: 17395597
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Bassett WW; Cooperberg MR; Sadetsky N; Silva S; DuChane J; Pasta DJ; Chan JM; Anast JW; Carroll PR; Kane CJ
    Urology; 2005 Nov; 66(5):1060-5. PubMed ID: 16286124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
    Wu JD; Haugk K; Woodke L; Nelson P; Coleman I; Plymate SR
    J Cell Biochem; 2006 Oct; 99(2):392-401. PubMed ID: 16639715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer.
    Skolarus TA; Wolin KY; Grubb RL
    Nat Clin Pract Urol; 2007 Nov; 4(11):605-14. PubMed ID: 17982437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I.
    Montagnani Marelli M; Moretti RM; Mai S; Procacci P; Limonta P
    Int J Oncol; 2007 Jan; 30(1):261-71. PubMed ID: 17143537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MAG member studies obesity risk factor for aggressive prostate cancer.
    J Med Assoc Ga; 2005; 94(2):40-1. PubMed ID: 16583815
    [No Abstract]   [Full Text] [Related]  

  • 60. Enforced epithelial expression of IGF-1 causes hyperplastic prostate growth while negative selection is requisite for spontaneous metastogenesis.
    Kaplan-Lefko PJ; Sutherland BW; Evangelou AI; Hadsell DL; Barrios RJ; Foster BA; Demayo F; Greenberg NM
    Oncogene; 2008 May; 27(20):2868-76. PubMed ID: 18026134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.